BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29042418)

  • 1. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
    Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
    Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
    Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
    Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
    Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
    J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.
    Zhang H; Luo H; Jiang Z; Yue J; Hou Q; Xie R; Wu S
    J Radiat Res; 2016 Jul; 57(4):370-80. PubMed ID: 27125498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma 94 enhances radiation treatment of esophageal squamous cell carcinoma in vitro and in vivo.
    Zhang H; Li J; Wang YY; Meng AM; Liu Q; Wang L; Chen FH; Wang XC; Zhai ZB; Fu Y; Wang Q
    J Radiat Res; 2012; 53(1):117-24. PubMed ID: 22302052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
    Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
    Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
    Zhang X; Yang X; Zhu S; Li Q; Zou N
    Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
    Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
    Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair.
    Zhou Y; Chu L; Wang Q; Dai W; Zhang X; Chen J; Li L; Ding P; Zhang L; Gu H; Li L; Lv X; Zhang W; Zhou D; Zhang P; Cai G; Zhao K; Hu W
    Cell Death Dis; 2018 Aug; 9(9):887. PubMed ID: 30166523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
    Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X
    Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.
    Cheng J; Liu W; Zeng X; Zhang B; Guo Y; Qiu M; Jiang C; Wang H; Wu Z; Meng M; Zhuang H; Zhao L; Hao J; Cai Q; Xie D; Pang Q; Wang P; Yuan Z; Qian D
    Cancer Sci; 2015 Dec; 106(12):1678-86. PubMed ID: 26383967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
    Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
    Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
    Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
    Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.
    Gu C; Luo J; Lu X; Tang Y; Ma Y; Yun Y; Cao J; Cao J; Huang Z; Zhou X; Zhang S
    Cancer Sci; 2019 Mar; 110(3):962-972. PubMed ID: 30657231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma.
    Zhu H; Song H; Chen G; Yang X; Liu J; Ge Y; Lu J; Qin Q; Zhang C; Xu L; Di X; Cai J; Ma J; Zhang S; Sun X
    Radiother Oncol; 2017 Sep; 124(3):439-447. PubMed ID: 28431753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
    He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
    Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.
    Zhou H; Zhang G; Xue X; Yang Y; Yang Y; Chang X; Ge X; Xiao Z; Guo H; Wang Y
    Tumour Biol; 2016 Jul; 37(7):8741-52. PubMed ID: 26738870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
    Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
    J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.